CAR T-Cell Therapy in Malignant Pleural and Peritoneal Mesothelioma - Surviving Mesothelioma

Antigen receptor T-cell therapy has recently shown clinical efficacy in phase I clinical trials for ignant mesothelioma patients.

One of the new therapies for mesothelioma is called antigen receptor T-cell therapy. It gives promise to malignant mesothelioma patients. This unique therapy has recently shown that it works in phase… [+2499 chars]

full article...